Editorial Comment to Therapeutic outcomes of neoadjuvant and concurrent androgen-deprivation therapy and intensity-modulated radiation therapy with gold marker implantation for intermediate and high-risk prostate cancer

Intensity Modulated ◽

Therapeutic Outcomes ◽

Risk Prostate Cancer ◽

Gold Marker

Therapeutic outcomes of neoadjuvant and concurrent androgen-deprivation therapy and intensity-modulated radiation therapy with gold marker implantation for intermediate-risk and high-risk prostate cancer

International Journal of Urology ◽

10.1111/iju.12707 ◽

2015 ◽

Vol 22 (5) ◽

pp. 477-482 ◽

Cited By ~ 4

Author(s):

Masayuki Kobayashi ◽

Kazuo Hatano ◽

Satoshi Fukasawa ◽

Atsushi Komaru ◽

Takeshi Namekawa ◽

...

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

High Risk ◽

Intermediate Risk ◽

Intensity Modulated ◽

Therapeutic Outcomes ◽

Risk Prostate Cancer ◽

Gold Marker

Cost-effectiveness of prostate boost with high-dose-rate brachytherapy versus intensity-modulated radiation therapy in the treatment of intermediate-high risk prostate cancer

Brachytherapy ◽

10.1016/j.brachy.2018.07.009 ◽

2018 ◽

Vol 17 (6) ◽

pp. 852-857 ◽

Cited By ~ 5

Author(s):

Charles C. Vu ◽

Kevin G. Blas ◽

Thomas B. Lanni ◽

Gary S. Gustafson ◽

Daniel J. Krauss

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

Cost Effectiveness ◽

High Risk ◽

High Dose Rate ◽

High Dose ◽

Intensity Modulated ◽

Ten-Year Results From a Phase II Study on Image Guided, Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in High-Risk Prostate Cancer

Advances in Radiation Oncology ◽

10.1016/j.adro.2019.11.007 ◽

2020 ◽

Vol 5 (3) ◽

pp. 396-403 ◽

Author(s):

Christian Ekanger ◽

Svein Inge Helle ◽

Daniel Heinrich ◽

Dag Clement Johannessen ◽

Ása Karlsdóttir ◽

...

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

High Risk ◽

Phase Ii Study ◽

Image Guided ◽

Intensity Modulated ◽

Risk Prostate Cancer ◽

Integrated Boost

Hypofractionated Intensity-Modulated Radiation Therapy (63 Gy in 21 fractions) for Intermediate and High Risk Prostate Cancer in a Japanese Institute

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2017.06.1200 ◽

2017 ◽

Vol 99 (2) ◽

pp. E250-E251

Author(s):

N. Kubo ◽

H. Kawamura ◽

H. Sato ◽

T. Mizukami ◽

J.I. Saitoh ◽

...

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

High Risk ◽

Intensity Modulated ◽

Concomitant Hypofractionated Intensity Modulated Radiation Therapy Boost For Localized High-Risk Prostate Cancer: Five-Year Results of a Prospective Trial

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2016.06.093 ◽

2016 ◽

Vol 96 (2) ◽

pp. S33 ◽

Author(s):

P. Cheung ◽

G. Morton ◽

E. Szumacher ◽

C. Danjoux ◽

H.T. Chung ◽

...

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

High Risk ◽

Prospective Trial ◽

Intensity Modulated ◽

Long-term outcomes of dose-escalated intensity modulated radiation therapy alone without androgen deprivation therapy for patients with intermediate and high-risk prostate cancer

Advances in Radiation Oncology ◽

10.1016/j.adro.2016.10.006 ◽

2016 ◽

Vol 1 (4) ◽

pp. 300-309 ◽

Cited By ~ 5

Author(s):

Rafael Gadia ◽

Elton Trigo Teixeira Leite ◽

Ana Luiza Bierrenbach ◽

Fabio Ynoe de Moraes ◽

Daniel E. Spratt ◽

...

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

High Risk ◽

Androgen Deprivation Therapy ◽

Long Term Outcomes ◽

Intensity Modulated ◽

Hypofractionated Intensity Modulated Radiation Therapy to Prostate and Pelvic Nodes Plus Androgen Suppression in High-Risk Prostate Cancer

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2018.06.354 ◽

2018 ◽

Vol 102 (3) ◽

pp. S146 ◽

Author(s):

S.L. Faria ◽

F. Cury ◽

M. Duclos ◽

L. Souhami

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

High Risk ◽

Intensity Modulated ◽

Risk Prostate Cancer ◽

Androgen Suppression

Association of urethral toxicity with dose exposure in combined high-dose-rate brachytherapy and intensity-modulated radiation therapy in intermediate- and high-risk prostate cancer

Radiotherapy and Oncology ◽

10.1016/j.radonc.2008.12.007 ◽

2009 ◽

Vol 91 (2) ◽

pp. 237-242 ◽

Cited By ~ 19

Author(s):

Pirus Ghadjar ◽

Oscar Matzinger ◽

Bernhard Isaak ◽

Frank Behrensmeier ◽

Andrea Stroux ◽

...

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

High Risk ◽

Dose Rate ◽

High Dose Rate ◽

High Dose ◽

Intensity Modulated ◽

Racial Disparity in Androgen Deprivation Therapy Utilization for Men with High-Risk Prostate Cancer Treated with Intensity-Modulated Radiation Therapy in the Modern Era – A SEER-Medicare Linked Database Analysis

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2018.07.286 ◽

2018 ◽

Vol 102 (3) ◽

pp. e147-e148 ◽

Author(s):

C. Wang ◽

A. Raldow ◽

C.R. King ◽

P.A. Kupelian ◽

N. Nickols ◽

...

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

High Risk ◽

Racial Disparity ◽

Database Analysis ◽

Intensity Modulated ◽

Risk Prostate Cancer ◽

Modern Era

Phase 2 Study: Feasibility and Acute Toxicity of Dose-Escalated Hypofractionated Intensity Modulated Radiation Therapy With Concurrent Treatment of Pelvic Lymph Nodes in High-Risk Prostate Cancer Patients

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2013.06.957 ◽

2013 ◽

Vol 87 (2) ◽

pp. S364

Author(s):

S. Drodge ◽

A. Boychak ◽

S. Patel ◽

N. Usmani ◽

J. Amanie ◽

...

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

High Risk ◽

Phase 2 ◽

Concurrent Treatment ◽

Intensity Modulated ◽

Phase 2 Study ◽